Adaptation of couples living with a high risk of breast/ovarian cancer and the association with risk-reducing surgery

被引:5
|
作者
Shapira, Rachel [1 ,4 ]
Turbitt, Erin [1 ]
Erby, Lori H. [1 ]
Biesecker, Barbara B. [1 ]
Klein, William M. P. [1 ,2 ]
Hooker, Gillian W. [3 ]
机构
[1] NHGRI, Social & Behav Res Branch, NIH, Bethesda, MD 20892 USA
[2] Natl Canc Ctr, Div Canc Control & Populat Sci, Behav Res Program, Rockville, MD USA
[3] Concert Genet, Franklin, TN USA
[4] UCLA Hlth, 200 Med Pl,Suite 122, Los Angeles, CA 90095 USA
关键词
Breast cancer; BRCA1; 2; Partner; Dyad; Risk reducing surgery; Adaptation; BILATERAL PROPHYLACTIC MASTECTOMY; OVARIAN-CANCER; BREAST-CANCER; HEREDITARY BREAST; MUTATION CARRIERS; WOMEN; ADJUSTMENT; DISTRESS; PARTNERS; BRCA1;
D O I
10.1007/s10689-017-0065-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Women who carry BRCA1/2 mutations have a significantly elevated risk for breast and ovarian cancer. The positive test result and subsequent decisions about risk reducing behaviors can evoke distress, anxiety and worry. Psychological adaptation, or the process of coming to terms with the implications of a health threat, is an understudied construct in BRCA1/2 carriers. Little is known about adaptation and how it relates to other aspects of living at high risk for cancer. Even less is understood about adaptation among partners of BRCA1/2 carriers, and its relationship to adaptation in high risk individuals. Women at increased risk of breast/ovarian cancer (N=103) and a subset of partners (N=39) completed questionnaires that assessed risk management decisions (e.g. screening, risk-reducing surgery), dyadic coping, and the outcome of psychological adaptation. Women who had undergone risk-reducing mastectomy (RRM) had significantly higher levels of adaptation than those who had not (t=5.5, p<0.001, d=1.10). Partners of women who had undergone RRM also had higher levels of adaptation than partners of women who had not undergone RRM (t=3.7, p=0.01, d=0.96), though this association was not statistically significant when controlling for carriers' adaptation. Undergoing risk-reducing oophorectomy was not associated with adaptation for BRCA1/2 carriers or their partners. Risk-reducing mastectomy is a significant event in the process of adapting to life at risk for hereditary cancer. Further, adaptation among partners is highly related to adaptation in carriers. These results aid in the understanding of the experience of couples living with cancer risk and the medical decisions related to adaptation.
引用
收藏
页码:485 / 493
页数:9
相关论文
共 50 条
  • [41] Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer
    Zheng Feng
    Ke Zuo
    Xingzhu Ju
    Xiaojun Chen
    Wentao Yang
    Hao Wen
    Lin Yu
    Xiaohua Wu
    Journal of Ovarian Research, 16
  • [42] Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk
    Terry, Mary Beth
    Daly, Mary B.
    Phillips, Kelly Anne
    Ma, Xinran
    Zeinomar, Nur
    Leoce, Nicole
    Dite, Gillian S.
    MacInnis, Robert J.
    Chung, Wendy K.
    Knight, Julia A.
    Southey, Melissa C.
    Milne, Roger L.
    Goldgar, David
    Giles, Graham G.
    Weideman, Prue C.
    Glendon, Gord
    Buchsbaum, Richard
    Andrulis, Irene L.
    John, Esther M.
    Buys, Saundra S.
    Hopper, John L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (03): : 331 - 334
  • [43] Association of Risk-Reducing Surgery With Cancer Risks and Mortality in BRCA Mutation Carriers
    Heemskerk-Gerritsen, Bernadette A. M.
    Kriege, Mieke
    Seynaeve, Caroline
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (24): : 2695 - 2695
  • [44] Evaluation of Screening and Risk Reducing Surgery for Women Followed in a High Risk Breast/Ovarian Cancer Clinic
    Stewart, Martha E.
    Knisely, Anne T.
    Sullivan, Mackenzie W.
    Ring, Kari L.
    Modesitt, Susan C.
    OBSTETRICS AND GYNECOLOGY, 2018, 131 : 15S - 15S
  • [45] Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriers
    Stewart, Martha E.
    Knisely, Anne T.
    Sullivan, Mackenzie W.
    Ring, Kari L.
    Modesitt, Susan C.
    GYNECOLOGIC ONCOLOGY REPORTS, 2019, 28 : 18 - 22
  • [46] Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer
    Schrauder, Michael G.
    Brunel-Geuder, Lisa
    Haeberle, Lothar
    Wunderle, Marius
    Hoyer, Juliane
    Reis, Andre
    Schulz-Wendtland, Ruediger
    Beckmann, Matthias W.
    Lux, Michael P.
    BREAST, 2017, 32 : 186 - 191
  • [47] The main site of origin for malignancies detected during risk-reducing surgery for ovarian cancer
    Morgan, Mark
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (03): : 134 - 135
  • [48] The main site of origin for malignancies detected during risk-reducing surgery for ovarian cancer
    Mark Morgan
    Nature Clinical Practice Oncology, 2008, 5 : 134 - 135
  • [49] Risk-reducing mastectomy for the prevention of primary breast cancer
    Carbine, Nora E.
    Lostumbo, Liz
    Wallace, Judi
    Ko, Henry
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (04):
  • [50] Impact of risk-reducing oophorectomy on quality of life in women at risk for ovarian cancer
    McArthur, H. L.
    Hensley, M.
    Brown, C. L.
    Chi, D. S.
    Offit, K.
    Hurley, K.
    Li, Y.
    Gemignani, M. L.
    Robson, M. E.
    Barakat, R. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)